Results 261 to 270 of about 1,109,000 (367)
CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target
Astrid Holzinger, Hinrich Abken
openalex +2 more sources
1. Chimeric antigen receptor T (CAR‐T) therapy has made some progress in the treatment of acute myeloid leukaemia (AML), among which C‐type lectin‐like molecule‐1 (CLL1) CAR‐T‐cell therapy has shown certain efficacy in the treatment of relapsed/refractory (R/R) AML. However, 30% of patients exhibit primary treatment resistance. Key factors limiting the
Rui Zhang +3 more
wiley +1 more source
Predictive Factors of Non-Elevation of Carcinoembryonic Antigen 125 in Acute Heart Failure. [PDF]
López-Vilella R +8 more
europepmc +1 more source
Curcumin's Therapeutic Potential in Ovarian Cancer: Current Insights and Future Perspectives
This review provides an overview of ovarian cancer, examines curcumin's emerging role in its treatment, identifies existing research gaps, and outlines a roadmap for future studies aimed at fully exploring curcumin's therapeutic potential in the management of ovarian cancer.
Smirnova Elena +7 more
wiley +1 more source
Predictive value of perioperative carcinoembryonic antigen changes for recurrence in non-small cell lung cancer. [PDF]
Sun H +10 more
europepmc +1 more source
Tryptophan metabolism‐related metabolic signature and transcription signature were explored, and four metabolites were determined as potential metabolic biomarkers of trastuzumab resistance. Then, the metabolic signature of potential metabolic biomarkers in serum discriminated TR patients from TS patients.
Xinxin Si +6 more
wiley +1 more source
Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen [PDF]
Hinoda, Yuji +5 more
core
A Seer‐Based Analysis of Survival Predictors in Stage I Colorectal Adenocarcinomas
ABSTRACT Background We assessed predictors of overall (OS) and cancer‐specific survival (CSS) in stage I colorectal cancer (CRC). Methods Retrospective analysis of patients with stage I colon or rectal adenocarcinomas from the SEER database (2010–2020) Survival was assessed using Kaplan‐Meier statistics and multivariable Cox regression analyses.
Sameh Hany Emile +5 more
wiley +1 more source

